SC administration. The current injection time for each LEQEMBI IQLIK autoinjector takes approximately 15 seconds. The SC formulation also has the potential to reduce healthcare resources associated with IV maintenance dosing, such as preparation...
have served a diverse set of programmes, consistently delivering value based on our quality and responsiveness. For more information please visit, https://www.sailife.com/
undersøger en unik triple-therapy (fosfomycin, metronidazol og GM-CSF), som gives direkte i bughulen under operationen. Formålet med studiet er at dokumentere, at RNX-011 kan reducere antallet af alvorlige postoperative komplikationer, såsom...
FIP world congress 2025, themed “Pharmacy Forward: Performance, Collaboration, and Health Transformation,” aims to explore the evolving role of the pharmacy profession in the context of modern healthcare challenges. FIP world congress 2025, themed...
CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, today announced the successful treatment of the first sickle...
updates. Dr. Michael Yu, Founder, Chairman of the Board and CEO of Innovent, stated: "We delivered an outstanding performance in the first half of 2025, driven by the comprehensive acceleration of our dual-engine growth model and global innovation...
aligns perfectly with our mission to provide patients with the essential medicines they need." IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS GVOKE VialDx is contraindicated in patients with: Pheochromocytoma, because of the risk of substantial...
of our next-generation IO therapy, IBI363 (PD-1/IL-2α-bias). If successful, this trial could bring a potentially transformative treatment to patients with squamous NSCLC worldwide, who currently have limited options after checkpoint inhibitor...
baseline to Week 8. "Completing enrollment in CYPRESS marks a major step toward bringing this potentially transformative therapy to patients with symptomatic nOH due to MSA – an underserved patient population in dire need for a new, effective and...
an international Pharmaceutical Conference can be a rewarding experience. Pharmacy Conferences 2025 will serve as a platform to meet and discuss new life saving drugs and medicines because that has become a necessity in the present day world. These...
in the lung arteries. VTB-10 is a first-in-class drug candidate developed using VASTHERA’s proprietary Redoxizyme™ platform. VASTHERA identified a deficiency of the enzyme peroxiredoxin (PRX) in PAH lesions and developed VTB-10, a small molecule...
solution that enables soft tissue regeneration in the breast — positioning CollPlant to be first-to-market with a transformative solution. Strong Preclinical Progress: Successfully 3D bioprinted 200cc commercial-size implants with enhanced...
GoodRx the leading platform for medication savings in the U.S., announced that via a collaboration with Novo Nordisk, all strengths of Ozempic® (semaglutide) and Wegovy® (semaglutide) pens are available to eligible self-paying patients for...
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, announced that the WHO prequalified Tropis ID delivery system will be used to support a polio eradication...
WA and Princeton, NJ. It specializes in developing innovative cancer treatments using its established drug development platforms, focusing on bi-specific, multi-specific antibodies, and antibody-drug conjugates (ADCs). SystImmune has several assets...
pediatrician and Genexa partner. “Genexa reflects what we as doctors want to see more of: clean, simple, and effective formulas for acute symptom relief.” The Brand at the Center of a Clean Medicine Movement: These findings reinforce broader market...
their proprietary semaglutide microneedle patch achieved more than 80%relative bioavailability compared to the injectable formulation in a pilot human pharmacokinetic study. This was based on the healthy volunteer study using semaglutide...
the Board of Abcentra and Managing Partner of Glenbarr Partners. "We believe orticumab has the potential to become a transformative therapy in cardiovascular disease and are proud to support this innovative approach targeting coronary inflammation,...
for the treatment of iron deficiency anemia (IDA) in patients with chronic kidney disease (CKD). IMPORTANT SAFETY INFORMATION CONTRAINDICATIONS Known hypersensitivity to iron sucrose. WARNINGS AND PRECAUTIONS Hypersensitivity reactions: Serious...
clients fully integrated services—including GMP plasmid DNA production, AAV vector manufacturing, and final drug product formulation and aseptic fill/finish—within a single U.S.-based location. This streamlined approach simplifies coordination,...
